• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 15F-12B filed by Aluminum Corporation of China Limited

    2/2/24 6:02:12 AM ET
    $ACH
    Medical Specialities
    Health Care
    Get the next $ACH alert in real time by email
    15F-12B 1 tm244874d1_15f12b.htm 15F-12B

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 15F

     

    CERTIFICATION OF A FOREIGN PRIVATE ISSUER’S TERMINATION OF

    REGISTRATION OF A CLASS OF SECURITIES UNDER SECTION 12(g) OF

    THE SECURITIES EXCHANGE ACT OF 1934 OR ITS TERMINATION OF THE DUTY TO

    FILE REPORTS UNDER SECTION 13(a) OR SECTION 15(d) OF

    THE SECURITIES EXCHANGE ACT OF 1934

     

    Commission File Number: 001-15264

     

    ALUMINUM CORPORATION OF CHINA LIMITED

    (Exact name of registrant as specified in its charter)

     

    No. 62 North Xizhimen Street

    Haidian District, Beijing

    People’s Republic of China 100082

    (86) 10 8229 8322

    (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

     

    Overseas Listed Foreign Shares, par value RMB1.00 per Share (“H Shares”)

     

    American Depositary Shares, Each Representing 25 H Shares

    (Title of each class of securities covered by this Form)

     

    Place an X in the appropriate box(es) to indicate the provision(s) relied upon to terminate the duty to file reports under the Securities Exchange Act of 1934:

     

    Rule 12h-6(a)  x

    (for equity securities)

    Rule 12h-6(d)  ¨

    (for successor registrants)

       

    Rule 12h-6(c)  ¨

    (for debt securities)

    Rule 12h-6(i)  ¨

    (for prior Form 15 filers)

     

     

     

     

     

    PART I

     

    Item 1.Exchange Act Reporting History

     

    A.Aluminum Corporation of China Limited (the “Company”) first incurred the duty to file reports under section 13(a) or section 15(d) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), in December 2001.

     

    The Company’s American Depositary Shares (the “ADSs”), each representing 25 H Shares, were listed on the New York Stock Exchange (the “NYSE”) on December 11, 2001. On August 22, 2022, the Company voluntarily filed Form 25 with the United States Securities and Exchange Commission (the “SEC”) and the delisting of the Company’s ADSs became effective as of 12:00 am Eastern Time on September 2, 2022. On June 30, 2023, the Company terminated its ADSs program.

     

    B.The Company has filed or submitted all reports required under Exchange Act section 13(a) or section 15(d) and corresponding rules of the SEC for the 12 months preceding the filing of this Form 15F. The Company has filed at least one annual report under section 13(a) of the Exchange Act.

     

    Item 2.Recent United States Market Activity

     

    The Company’s securities were last sold in the United States in December 2001 in a registered offering under the Securities Act of 1933, as amended, pursuant to a registration statement on Form F-1 (No. 333-14068), as amended.

     

    Item 3.Foreign Listing and Primary Trading Market

     

    A.The foreign exchange on which the Company has maintained a listing of its H Shares is The Stock Exchange of Hong Kong Limited (the “SEHK”) and such exchange constitutes the primary trading market for the Company’s H Shares.

     

    B.The Company was initially listed on the SEHK in December 2001. The Company has maintained the listing of its H Shares on the SEHK for at least the 12 months preceding the filing of this Form 15F.

     

    C.The percentage of trading in the Company’s H Shares (including those represented in the form of ADSs) that occurred on the SEHK for the 12-month period from February 1, 2023 to January 31, 2024 (both dates inclusive) was approximately 99.8%.

     

    Item 4.Comparative Trading Volume Data

     

    A.The first and last days of the recent 12-month period used to meet the requirements of Rule 12h-6(a)(4)(i) under the Exchange Act are February 1, 2023 and January 31, 2024.

     

    B.The average daily trading volume of the Company’s H Shares (including those represented in the form of ADSs) in the United States (both on-exchange and off-exchange) was approximately 47,441 shares for the same 12-month period. The average daily trading volume of the Company’s H Shares (including those represented in the form of ADSs) worldwide was approximately 21,410,879 shares for the same 12-month period.

     

    C.The average daily trading volume of the Company’s H Shares (including those represented in the form of ADSs) in the United States as a percentage of the average daily trading volume for the H Shares (including those represented in the form of ADSs) on a worldwide basis for the period described in Item 4.A was approximately 0.2%.

     

    D.The Company’s ADSs were delisted from the NYSE effective as of 12:00 am Eastern Time on September 2, 2022. As of that date, the average daily trading volume of the Company’s H Shares (including those represented in the form of ADSs) in the United States as a percentage of the average daily trading volume for the H Shares (including those represented in the form of ADSs) on a worldwide basis for the preceding 12-month period was approximately 6.4%.

     

     

     

     

    E.The Company has terminated its ADSs program on June 30, 2023. As of that date, the average daily trading volume of the Company’s H Shares (including those represented in the form of ADSs) in the United States as a percentage of the average daily trading volume for the H Shares (including those represented in the form of ADSs) on a worldwide basis for the preceding 12-month period was approximately 2.7%.

     

    F.All trading volume information was obtained from Wind Information Co., Ltd., a leading provider of financial information services in China.

     

    Item 5.Alternative Record Holder Information

     

    Not applicable.

     

    Item 6.Debt Securities

     

    Not applicable.

     

    Item 7.Notice Requirement

     

    A.The Company published a notice, as required by Rule 12h-6(h) under the Exchange Act, disclosing its intent to terminate its duty to file reports under section 13(a) and section 15(d) of the Exchange Act on August 12, 2022.

     

    B.The Company disseminated this notice in the United States through ACN Newswire. In addition, this notice was posted on the Company’s website. The Company submitted a copy of the notice to the SEC under cover of a Form 6-K on August 12, 2022.

     

    Item 8.Prior Form 15 Filers

     

    Not applicable.

     

    PART II

     

    Item 9.Rule 12g3-2(b) Exemption

     

    The Company will publish the information required under Rule 12g3-2(b)(1)(iii) on its Internet website at www.chalco.com.cn.

     

    PART III

     

    Item 10.Exhibits

     

    None.

     

    Item 11.Undertakings

     

    The undersigned issuer hereby undertakes to withdraw this Form 15F if, at any time before the effectiveness of its termination of reporting under Rule 12h-6, it has actual knowledge of information that causes it reasonably to believe that, at the time of filing the Form 15F:

     

    (1) The average daily trading volume of its subject class of securities in the United States exceeded 5 percent of the average daily trading volume of that class of securities on a worldwide basis for the same recent 12-month period that the issuer used for purposes of Rule 12h-6(a)(4)(i);

     

    (2) Its subject class of securities was held of record by 300 or more United States residents or 300 or more persons worldwide, if proceeding under Rule 12h-6(a)(4)(ii) or Rule 12h-6(c); or

     

    (3) It otherwise did not qualify for termination of its Exchange Act reporting obligations under Rule 12h-6.

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, Aluminum Corporation of China Limited has duly authorized the undersigned person to sign on its behalf this certification on Form 15F. In so doing, Aluminum Corporation of China Limited certifies that, as represented on this Form, it has complied with all of the conditions set forth in Rule 12h-6 for terminating its registration under section 12(g) of the Exchange Act, or its duty to file reports under section 13(a) or section 15(d) of the Exchange Act, or both.

     

    Date: February 2, 2024

     

      ALUMINUM CORPORATION OF CHINA LIMITED
           
      By: /s/ Ge Xiaolei
        Name: Ge Xiaolei
        Title:

    Chief Financial Officer and Secretary to the Board

     

     

     

    Get the next $ACH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACH

    DatePrice TargetRatingAnalyst
    8/25/2022Sell → Neutral
    Goldman
    3/23/2022Reduce → Hold
    HSBC Securities
    More analyst ratings

    $ACH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Pesicka Edward A

    4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)

    3/24/26 5:45:07 PM ET
    $ACH
    Medical Specialities
    Health Care

    SEC Form 4 filed by Leon Jonathan A

    4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)

    3/24/26 5:42:40 PM ET
    $ACH
    Medical Specialities
    Health Care

    SEC Form 4 filed by Bernocchi Perry A

    4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)

    3/24/26 5:40:48 PM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Accendra Health Reports Fourth Quarter 2025 Financial Results

    Completed Sale of Products & Healthcare Services Business On December 31, 2025 Strong Cash Flow and Debt Reduction In Quarter Accendra Health, Inc. (NYSE:ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect the Company's continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. "We ended the fourth quarter with the completion of the sale of the Products & Healthcare Services (P&HS) business on December 31, 2025, and we are extremely excited to embark on the next chapter of our business as Accendra Health. The next several months w

    2/19/26 4:05:00 PM ET
    $ACH
    Medical Specialities
    Health Care

    Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call

    Accendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the fourth quarter of 2025 on Thursday, February 19, 2026, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EST on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Accendra Health website available at investors.accendra.com/events-and-presentations/. A repl

    2/5/26 4:05:00 PM ET
    $ACH
    Medical Specialities
    Health Care

    Accendra Health, Inc. to Begin Trading on NYSE under New Ticker "ACH"

    Accendra Health, Inc. (NYSE:ACH) (the "Company") announced that the Company's common stock will begin trading on the New York Stock Exchange under its new ticker symbol, "ACH", effective today. The Company also announced the launch of its new website, www.accendrahealth.com. On December 31, 2025, the Company announced the completion of the sale of its former Products & Healthcare Services business along with the Owens & Minor brand. Safe Harbor This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This release contains certain "forward looking" s

    1/2/26 6:30:00 AM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    SEC Filings

    View All

    SEC Form DEFA14A filed by Accendra Health Inc.

    DEFA14A - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)

    4/2/26 6:30:09 AM ET
    $ACH
    Medical Specialities
    Health Care

    SEC Form DEF 14A filed by Accendra Health Inc.

    DEF 14A - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)

    4/2/26 6:25:26 AM ET
    $ACH
    Medical Specialities
    Health Care

    SEC Form 10-K filed by Accendra Health Inc.

    10-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)

    2/20/26 4:19:33 PM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alum. Corp China upgraded by Goldman

    Goldman upgraded Alum. Corp China from Sell to Neutral

    8/25/22 1:04:06 PM ET
    $ACH
    Medical Specialities
    Health Care

    Alum. Corp China upgraded by HSBC Securities

    HSBC Securities upgraded Alum. Corp China from Reduce to Hold

    3/23/22 7:04:02 AM ET
    $ACH
    Medical Specialities
    Health Care

    Alum. Corp China upgraded by JP Morgan

    JP Morgan upgraded Alum. Corp China from Neutral to Overweight

    4/8/21 12:27:37 PM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    Financials

    Live finance-specific insights

    View All

    Accendra Health Reports Fourth Quarter 2025 Financial Results

    Completed Sale of Products & Healthcare Services Business On December 31, 2025 Strong Cash Flow and Debt Reduction In Quarter Accendra Health, Inc. (NYSE:ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect the Company's continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. "We ended the fourth quarter with the completion of the sale of the Products & Healthcare Services (P&HS) business on December 31, 2025, and we are extremely excited to embark on the next chapter of our business as Accendra Health. The next several months w

    2/19/26 4:05:00 PM ET
    $ACH
    Medical Specialities
    Health Care

    Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call

    Accendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the fourth quarter of 2025 on Thursday, February 19, 2026, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EST on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Accendra Health website available at investors.accendra.com/events-and-presentations/. A repl

    2/5/26 4:05:00 PM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed

    SC 13G/A - ALUMINUM CORP OF CHINA LTD (0001161611) (Subject)

    2/16/21 3:46:32 PM ET
    $ACH
    Medical Specialities
    Health Care